Office of National Drug Control Policy (ONDCP) Resources
Funding
Funding to address substance use disorders (SUDs) and related issues. List may include programs with a primary purpose other than addressing SUDs.
Supports research projects that implement innovative strategies to reduce opioid, stimulant, and/or poly-drug overdose in high-risk communities. Promotes the use of evidence-based practices in new or existing programs and emphasizes the evaluation of new and promising approaches. Establishes partnerships between public safety and public health agencies to address harms related to opioid, stimulant, and poly-substance use and overdose.
Information
Outlines federal drug policy priorities and promotes short and long-term solutions to reduce drug use, overdose, and other related harms in the U.S. Priorities include: expanding access to medication for opioid use disorder and other evidence-based treatment; advancing racial equity in drug policy; enhancing harm reduction efforts; supporting youth substance use prevention; reducing the supply of illicit substances; advancing recovery-ready workplaces; and expanding addiction workforce and access to recovery support services. Includes strategies to address substance use issues in rural and underserved communities.
Identifies and describes the following 7 drug policy priorities for the first year of the Biden-Harris Administration: expanding access to evidence-based treatment; advancing racial equity issues in drug policy; enhancing evidenced-based harm reduction efforts; supporting evidence-based prevention efforts to reduce youth substance use; reducing the supply of illicit substances; advancing recovery-ready workplaces and increasing the addiction workforce; and expanding access to recovery support services. Outlines next steps for the Office of National Drug Control Policy (ONDCP) to coordinate with other federal agencies to address drug policy priorities.
Consists of a public health and public safety collaboration between the High Intensity Drug Trafficking Areas (HIDTA) program and the Centers for Disease Control and Prevention (CDC) across the U.S. Seeks to help communities reduce fatal and non-fatal drug overdose rates by improving information sharing across agencies and supporting evidence-based interventions. Equips states with a Drug Intelligence Officer (DIO) and a Public Health Analyst (PHA) who are responsible for helping to increase communication, data flow, and intelligence sharing between public safety and public health sectors within and across states.
Video recording of a workshop discussion intended to help rural faith leaders understand substance use prevention and identify and implement evidence-based prevention strategies in rural communities. Provides information on substance use prevention, treatment, and recovery in a rural context. Highlights ways that faith communities can partner with other stakeholders to develop prevention programs and activities and offers several faith-based prevention program models.
Video recording of a workshop discussion on the intersection of substance use disorder (SUD) and the COVID-19 pandemic to help rural faith leaders learn and share information and resources to help individual and families struggling with addiction. Covers opioid use/misuse and COVID-19 in rural areas; the economic impacts of SUD on small communities before and during the pandemic; finding and using data to understand the problem in individual communities; helping faith-based and community leaders bring hope and healing to communities; and congregation readiness.